AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Ostendorf, T Kunter, U Grone, HJ Bahlmann, F Kawachi, H Shimizu, F Koch, KM Janjic, N Floege, J
Citation: T. Ostendorf et al., Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis, J AM S NEPH, 12(5), 2001, pp. 909-918

Authors: Lonnemann, G Koch, KM
Citation: G. Lonnemann et Km. Koch, Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis, NEPH DIAL T, 16, 2001, pp. 17-22

Authors: Ketteler, M Koch, KM Floege, J
Citation: M. Ketteler et al., Imaging techniques in the diagnosis of dialysis-related amyloidosis, SEMIN DIAL, 14(2), 2001, pp. 90-93

Authors: Koch, KM Ricci, BM Hedayetullah, NS Jewell, D Kersey, KE
Citation: Km. Koch et al., Effect of alosetron on theophylline pharmacokinetics, BR J CL PH, 52(5), 2001, pp. 596-600

Authors: D'Souza, DL Levasseur, LM Nezamis, J Robbins, DK Simms, L Koch, KM
Citation: Dl. D'Souza et al., Effect of alosetron on the pharmacokinetics of alprazolam, J CLIN PHAR, 41(4), 2001, pp. 452-454

Authors: D'Souza, DL Dimmitt, DC Robbins, DK Nezamis, J Simms, L Koch, KM
Citation: Dl. D'Souza et al., Effect of alosetron on the pharmacokinetics of fluoxetin, J CLIN PHAR, 41(4), 2001, pp. 455-458

Authors: Kurts, C Klebba, I Davey, GM Koch, KM Miller, JFAP Heath, WR Floege, J
Citation: C. Kurts et al., Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration, KIDNEY INT, 60(2), 2001, pp. 664-671

Authors: Radermacher, J Chavan, A Bleck, J Vitzthum, A Stoess, B Gebel, MJ Galanski, M Koch, KM Haller, H
Citation: J. Radermacher et al., Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis, N ENG J MED, 344(6), 2001, pp. 410-417

Authors: O'Connor-Semmes, RL Kersey, K Williams, DH Lam, R Koch, KM
Citation: Rl. O'Connor-semmes et al., Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) people, CLIN PHARM, 70(2), 2001, pp. 126-131

Authors: Lonnemann, G Floege, J Kliem, V Brunkhorst, R Koch, KM
Citation: G. Lonnemann et al., Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system, NEPH DIAL T, 15(8), 2000, pp. 1189-1193

Authors: Schaffer, J Burchert, W Floege, J Gielow, P Kionka, C Linke, RP Weiss, EH Shaldon, S Koch, KM
Citation: J. Schaffer et al., Recombinant versus natural human In-111-beta(2)-microglobulin for scintigraphic detection of A beta(2)m amyloid in dialysis patients, KIDNEY INT, 58(2), 2000, pp. 873-880

Authors: Kurts, C Carbone, FR Krummel, MF Koch, KM Miller, JFAP Heath, WR
Citation: C. Kurts et al., Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells (vol 398, pg 341, 1999), NATURE, 407(6802), 2000, pp. 413

Authors: Koch, KM
Citation: Km. Koch, Nephrology: Advances and economic restraints, DEUT MED WO, 124(51-52), 1999, pp. 1559-1561

Authors: Gwinner, W Plasger, J Brandes, RP Kubat, B Schulze, M Regele, H Kerjaschki, D Olbricht, CJ Koch, KM
Citation: W. Gwinner et al., Role of xanthine oxidase in passive Heymann nephritis in rats, J AM S NEPH, 10(3), 1999, pp. 538-544

Authors: Kielstein, JT Boger, RH Bode-Boger, SM Schaffer, J Barbey, M Koch, KM Frolich, JC
Citation: Jt. Kielstein et al., Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease, J AM S NEPH, 10(3), 1999, pp. 594-600

Authors: Haubitz, M Busch, T Gerlach, M Schafer, S Brunkhorst, R Falke, K Koch, KM Gerlach, H
Citation: M. Haubitz et al., Exhaled nitric oxide in patients with Wegener's granulomatosis, EUR RESP J, 14(1), 1999, pp. 113-117

Authors: Maschio, G Alberti, D Locatelli, F Mann, JFE Motolese, M Ponticelli, C Ritz, E Janin, G Zucchelli, P Marai, P Marcelli, D Tentori, F Andriani, M Drago, G Meneghel, G Oldrizzi, L Rugiu, C Salvadeo, A Villa, G Picardi, L Borghi, M Moriggi, M Vendramin, G Fusaroli, M Esposti, ED Fabbri, A Zucchelli, P Zuccali, A Gaggi, R Ponticelli, C Rivolta, E Buccianti, G Gastaldi, L Baratelli, M Pedrini, L Faranna, P Cairo, G Ferrari, L Albertazzi, A Cappelli, P Canti, P Limido, A Mioni, G Montanaro, D Sasdelli, M Imperiali, P Cagnoli, L Rigotti, A Grassi, C Orazi, E Borgatti, PP Stefani, A Redaelli, B Vigan, MR Giangrande, A Ramello, A Imbasciati, E Palla, R Sessa, A Aitieri, P Verzetti, G Baroni, C Costanzo, R Bandiani, G Ducret, F Pointet, P Janin, G Nefti, H Maret, J Cledes, J Cordonnier, D Sirajedin, K Aparicio, M Mery, JP Idatte, JM Bariety, J Wolf, C Marichal, JF Koch, KM Frey, U Schaeffer, J Ritz, E Mann, J Schweitzer, C Stahl-Blaser, R Mann-Sterzel, J Oberdorf, E Lachein, L Bosselmann, HP Schmidt, R Irmhild, H Stein, G Laske, N
Citation: G. Maschio et al., Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial, J CARDIO PH, 33, 1999, pp. S16-S20

Authors: Lonnemann, G Bechstein, M Linnenweber, S Burg, M Koch, KM
Citation: G. Lonnemann et al., Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure, KIDNEY INT, 56, 1999, pp. S84-S87

Authors: Kliem, V Boeck, A Eisenberger, U Petersen, R Radermacher, J Hiss, M Pethig, M Koch, KM Nashan, B Brunkhorst, R
Citation: V. Kliem et al., Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: Single-center experience in 40 patients, TRANSPLAN P, 31(1-2), 1999, pp. 1312-1313

Authors: Kurts, C Carbone, FR Krummel, MF Koch, KM Miller, JFAP Heath, WR
Citation: C. Kurts et al., Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells, NATURE, 398(6725), 1999, pp. 341-344

Authors: Schaffer, J Floege, J Koch, KM
Citation: J. Schaffer et al., Long-tern care of dialysis patients. 1. Hypertension and anemia, INTERNIST, 40(1), 1999, pp. 55-63

Authors: Floege, J Segerer, S Schaffer, J Koch, KM
Citation: J. Floege et al., Long-term care of dialysis patients. 2. Beta-2-microglobulin-associated amyloidosis and acquired cystic kidney disease, INTERNIST, 40(1), 1999, pp. 64-69
Risultati: 1-22 |